Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium

被引:13
|
作者
Marth, C
Windbichler, G
Petru, E
Dirschlmayer, W
Obermair, A
Czerwenka, K
MullerHolzner, E
Dapunt, O
机构
[1] UNIV INNSBRUCK HOSP,DEPT OBSTET & GYNECOL,INNSBRUCK,AUSTRIA
[2] UNIV HOSP,DEPT OBSTET & GYNECOL,GRAZ,AUSTRIA
[3] UNIV HOSP,DEPT OBSTET & GYNECOL,VIENNA,AUSTRIA
[4] HOSP BARMHERZIGEN SCHWESTERN,LINZ,AUSTRIA
关键词
MULLERIAN TUMORS; UTERUS;
D O I
10.1006/gyno.1996.4538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant mixed mesodermal tumors (MMMT) are the most malignant neoplasms known to occur in the uterus. The most important prognostic factors are the extent of tumor at diagnosis, depth of myometrial invasion, and, as regarded by some authors, the sarcomatous component, We report on a retrospective analysis in 83 patients with MMMT. By univariate analysis survival was dependent on stage, depth of myometrial invasion, kind of therapy, age at menopause, and parity. However, the sarcomatous component did not significantly influence survival. Using the multivariate Cox regression analysis stage and parity or depth of myometrial invasion and parity were found to independently predict prognosis. Despite an interval of more than 20 years from the last childbirth to tumor appearance a beneficial influence of parity on the prognosis of MMMT was identified. This is unique in oncology. Especially patients with more than three children formed a subgroup of long-term survivors. It is interesting to note that parity was found by means of a Cox regression analysis to be statistically independent, and no correlation with other classical prognostic factors was detected. (C) 1997 Academic Press
引用
收藏
页码:121 / 125
页数:5
相关论文
共 50 条
  • [1] PARITY AS PROGNOSTIC FACTOR FOR MALIGNANT MIXED MULLERIAN TUMORS
    MARTH, C
    KOZA, A
    MULLERHOLZNER, E
    FUITH, LC
    HETZEL, H
    DAPUNT, O
    LANCET, 1989, 1 (8644): : 957 - 957
  • [2] PROGNOSTIC FACTORS IN MALIGNANT MESODERMAL (MULLERIAN) MIXED TUMORS OF THE UTERUS
    MACASAET, MA
    WAXMAN, M
    FRUCHTER, RG
    BOYCE, J
    HONG, P
    NICASTRI, AD
    REMY, JC
    GYNECOLOGIC ONCOLOGY, 1985, 20 (01) : 32 - 42
  • [3] MALIGNANT MIXED MESODERMAL TUMORS OF THE OVARY
    DISILVESTRO, PA
    GAJEWSKI, WH
    LUDWIG, ME
    KOUREA, H
    SUNG, J
    GRANAI, CO
    OBSTETRICS AND GYNECOLOGY, 1995, 86 (05): : 780 - 782
  • [4] MALIGNANT MIXED MESODERMAL TUMOR OF THE ENDOMETRIUM - A CLINICOPATHOLOGICAL STUDY
    SILVERBERG, SG
    MAJOR, F
    MORROW, P
    BLESSING, J
    CREASMAN, W
    CURRY, J
    LABORATORY INVESTIGATION, 1988, 58 (01) : A86 - A86
  • [5] MALIGNANT MIXED MESODERMAL TUMOR OF THE ENDOMETRIUM - A CLINICOPATHOLOGICAL STUDY
    SILVERBERG, SG
    MAJOR, F
    MORROW, P
    BLESSING, J
    CREASMAN, W
    CURRY, J
    MODERN PATHOLOGY, 1988, 1 (01) : A86 - A86
  • [6] MALIGNANT MIXED MULLERIAN NEOPLASMS (MIXED MESODERMAL TUMORS)
    KRUPP, PJ
    STERNBERG, WH
    CLARK, WH
    STROMAIN, MJ
    SMITH, RC
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1961, 81 (05) : 959 - &
  • [7] HISTOGENESIS OF OVARIAN MALIGNANT MIXED MESODERMAL TUMORS
    CLARKE, TJ
    JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (04) : 287 - 290
  • [8] MANAGEMENT OF MALIGNANT, MIXED MESODERMAL TUMORS OF THE UTERUS
    PODCZASKI, ES
    WOOMERT, CA
    STEVENS, CW
    MANETTA, A
    LARSON, JE
    ZAINO, RJ
    MORTEL, R
    GYNECOLOGIC ONCOLOGY, 1989, 32 (02) : 240 - 244
  • [9] MALIGNANT MIXED MESODERMAL TUMORS - CARCINOMA, SARCOMA, OR BOTH
    GORSTEIN, F
    ANDERSON, TL
    HUMAN PATHOLOGY, 1991, 22 (03) : 207 - 209
  • [10] Cytogenetic findings in malignant mixed mesodermal tumors of the uterus
    GilBenso, R
    LopezGines, C
    CardaBatalla, C
    MonteagudoCrespo, C
    Torres, JV
    LlombartBosch, A
    CANCER GENETICS AND CYTOGENETICS, 1997, 99 (02) : 121 - 125